Skip to main content

Enforcing BMI Cutoffs for Shoulder Joint Surgery Could Exacerbate Disparities

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Aug. 2, 2023 -- Enforcing body mass index (BMI) cutoffs for access to total shoulder arthroplasty (TSA) may limit the procedure for female or Black patients across all BMI cutoffs, according to a study recently published in the Journal of Shoulder and Elbow Surgery.

Ronit Kulkarni, from the Medical University of South Carolina in Charleston, and colleagues assessed the implications of using BMI cutoffs (five cutoff values: 30, 35, 40, 45, and 50 kg/m2) on the eligibility for TSA among different ethnic and gender patient populations. The analysis included data from 20,872 patients who underwent anatomic and reverse TSA between 2015 and 2019.

The researchers found that for all BMI subgroups, there were significantly more ineligible than eligible patients who were female or Black. In each BMI cutoff group, the relative rate of eligibility for Black patients was lower, whereas the relative rate of eligibility for White and Asian patients was higher. For BMI cutoffs of 30 kg/m2 and 35 kg/m2, there were more eligible than ineligible Asian patients, and there were no significant differences in eligibility and ineligibility in Hispanic patients. White patients were significantly more eligible than ineligible for all BMI cutoff groups.

"Physicians may inadvertently increase health care disparities observed in TSA if they use BMI as the sole risk stratification tool for patients, even though BMI has been known to increase complications after TSA," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2023

Read this next

Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer

TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be increased with neoadjuvant...

Small Differences in Weight Change With First-Line Antidepressants

MONDAY, July 1, 2024 -- For eight first-line antidepressants, small differences are seen in mean weight change, with the least weight gain with bupropion, according to a study...

Few Patients With Positive Margins After Basal Cell Excision Have Recurrence

MONDAY, July 1, 2024 -- Among patients with incompletely excised basal cell carcinoma (BCC), only about 16 percent with positive histopathologic margins have clinical recurrence...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.